Diabetes and Coronary Risk Equivalency-Reference-Cited by-同舟云学术

Diabetes and Coronary Risk Equivalency

Published:2006-02-01 Issue:2 Volume:29 Page:457-460
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Grundy Scott M.¹

Affiliation:

1. Center for Human Nutrition and Departments of Clinical Nutrition and Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/29/2/457/594337/zdc00206000457.pdf

Reference45 articles.

1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106:3143–3421, 2002

2. Garg A: Statins for all patients with type 2 diabetes: not so soon. Lancet 364:641–642, 2004

3. Howard BV, Best LG, Galloway JM, Howard WJ, Jones K, Lee ET, Ratner RE, Resnick HE, Devereux RB: Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care 29:391–397, 2006

4. Evans JM, Wang J, Morris AD: Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. BMJ 324:939–942, 2002

5. Lottufo PA, Gaziano JM, Chae CU, Ajani UA, Moreno-John G, Buring JE: Diabetes and all cause and coronary heart disease mortality among US male physicians. Arch Intern Med 161:242–247, 2001

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous point‐of‐care testing of blood lipid profile and glucose: Performance evaluation of the GCare Lipid Analyzer;Journal of Clinical Laboratory Analysis;2021-10-25

2. Heterogeneity amongst GLP-1 RA cardiovascular outcome trials results: can definition of established cardiovascular disease be the missing link?;Diabetology & Metabolic Syndrome;2021-07-27

3. Chronic kidney disease prevalence and cardiovascular risk in a cohort of patients with type 2 diabetes followed for 10 years in Badajoz (Spain). An observational study;Primary Care Diabetes;2021-04

4. Mechanisms of Kidney and Heart Cross-talk in Acute Kidney Injury;Textbook of Cardiorenal Medicine;2020-11-25

5. Myocardial perfusion imaging for diabetes: Key points from the evidence and clinical questions to be answered;Journal of Nuclear Cardiology;2019-08-13